Research Article

Simple and Objective Prediction of Survival in Patients with Lung Cancer: Staging the Host Systemic Inflammatory Response

Table 6

The relationship between parameters and survival in patients with mGPS = 2 .

ParameterPatientsUnivariateMultivariate
HR (95% CI) valueHR (95% CI) value

Age
 <60/60–69/70–79/≥8034/57/91/491.13 (0.98–1.30)0.084
Sex
 Male13310.136
 Female980.81 (0.61–1.07)
Centre
 Aberdeen4310.002
 Fife161.71 (0.95–3.06)
 Stobhill1140.64 (0.45–0.92)
 Inverclyde450.88 (0.57–1.35)
Deprivation (quintile) (most deprived = 1, least deprived = 5)
 1/2/3/4/5111/21/70/20/91.05 (0.94–1.17)0.408
Smoking history (NS = never smoker, otherwise pack years)
 NS/<20/20–60/>6013/21/128/570.83 (0.69–1.00)0.062
Performance status
 0/1/2/3/45/51/88/66/211.51 (1.30–1.76)<0.0011.44 (1.21–1.71)<0.001
Weight loss (% body weight)
 0/<5/5–10/>1079/45/33/731.25 (1.11–1.40)<0.0011.13 (1.00–1.28)0.047
FEV1 (%)
 >80/80–60/59–40/<40130/33/47/170.88 (0.77–1.01)0.073
Local symptoms
 No/Yes29/1371.51 (0.98–2.33)0.063
Stage
 NSCLC
  I/II/IIIa/IIIb/IV7/5/12/36/791.32 (1.15–1.50)<0.001
 SCLC
  Limited/extensive8/181.01 (0.91–1.12)0.826
Treatment
 Radical
  BSC/surgery/RT18/2/40.52 (0.33–0.83)0.006
 Palliative
  Chemo/RT/BSC50/49/750.92 (0.78–1.10)0.364